Translating science
into innovative
diagnostic solutions

Latest news

Wastewater surveillance

Our company, in collaboration with Syracuse University, SUNY Upstate Medical University, SUNY College of Environmental and Forestry, and global engineering firm Arcadis, is analyzing wastewater across New York State for the COVID-19 virus.

Wastewater surveillance acts as an early warning system for COVID-19 by detecting the presence of viral RNA shed into the sewer systems. Our analysis of wastewater samples will provide local health officials and policymakers with early indications and information regarding the presence and preponderance of COVID-19 infections in these communities.

Click on these links to recent press about this collaborative project:

60 minutes story

Governor Cuomo’s Press release

More news

Using ICO For Issuance Of Common Equity: More Is Coming

INTL BUSINESS TIMES

START UP NY connects Upstate Medical University and Motion Intelligence on concussion management

UPSTATE NEWS

Researchers Discover Key Link to Understanding Sleep Disorders

MARKETS INSIDER

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

GENOMEWEB

The Scoop: Tracking MicroRNAs to Study Brain Dysfunction

GEN ENG NEWS

Quadrant Biosciences Partners with Leading Edge Genomic Testing Company Admera Health

CISION PR NEWSWIRE

Central New York is mounting a sustainable comeback

SYRACUSE

Salivary microRNA may predict duration and nature of concussion symptoms among children

MARKET INSIDER

Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers...

BUSINESS WIRE

Renowned autism researcher Dr. Thomas Frazier joins Quadrant Biosciences Clinical Advisory Board

EIN PRESSWIRE

Spit Test May Reveal The Severity Of A Child's Concussion

NPR

Researchers Discover Novel BioMarker in Saliva that Identifies Concussion in Children and Predicts Length of Recovery

HUFF POST

University Scientists Selected to Implement COVID-19 Early Warning System in Upstate New York

SUNY ESF

Study finds correlation between specific epigenetic molecules and autism traits

BIO SPACE

New York State partners with Arcadis to pilot early detection of COVID-19 in wastewater

GLOBE NEWSWIRE

Motion Intelligence rolls out two assessment tests

CNYBJ

Microbes in Saliva May Offer Way of Detecting and Understanding Early Stages of Parkinson’s, Study Says

PARKINSON'S NEWS

DNA Genotek’s top 10 list for 2017

THE GENETIC LINK

Saliva test for COVID-19 approved by NY Dept. of Health

WHAM

Motion Intelligence Inc. changes name to Quadrant Biosciences Inc. to Better Reflect Broader Business Focus

MARKET WATCH

Quadrant Biosciences Recognized as New York Technology Business of the Year

MARKET WATCH

Oral microbial activity may help identify autism in children

HEALIO

Quadrant Biosciences to Collaborate on Signature Study of Minocycline Treatment of Autism Spectrum Disorder

AP NEWS

Novel biomarker in saliva offers breakthrough information on concussion in children

UPSTATE ONLINE

Company That just Released World’s First Saliva Test for Autism Opens Up Investment Opportunity to the Public

EIN PRESSWIRE

Quadrant Biosciences Launches First Ever Epigenetic Saliva Test for Autism

MARKET WATCH

Saliva test can predict concussion duration in children

MEDICAL RESEARCH

Saliva-based RNA panel distinguishes children on autism spectrum from non-autistic peers

EUREK ALERT

Research Aims to Overcome the Complexities Of Concussions For Better Patient Treatment

SUNY

Spit Test May Help Reveal Concussion Severity

NPR

SUNY may implement biweekly testing to stem campus COVID-19 outbreaks

NEW YORK POST

Quadrant Biosciences Inc. Announces Commercial Release of ClearEdge Brain Health Toolkit

HUFFPOST

THE FATE OF FOOTBALL: Spitting image — new test helps identify concussions

DAILY NEWS

Governor Cuomo Announces New Testing Initiatives to Improve COVID-19 Detection & Control Across New York State

NYS GOVERNOR'S OFFICE

Wall Street Veteran Peter Cohen joins Quadrant Biosciences Board of Directors

CISION PR NEWSWIRE

Rochester doctors hope new saliva tests swiftly diagnose concussions

SPECTRUM NEWS

Quadrant Biosciences Enters into Licensing Agreements with SUNY Upstate and Penn State for Commercialization of Novel Epigenetic Biomarkers

CISION PR NEWSWIRE

Quadrant Biosciences Receives CPT Proprietary Laboratory Analyses Code from the American Medical Association

EIN PRESSWIRE

Quadrant Biosciences Takes Next Step in the Detection of Autism

CISION PR NEWSWIRE

Spit test may diagnose, predict duration of concussion in kids

CNN

Our aim is to develop solutions for important global health issues

Quadrant Biosciences is an epigenetic diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary advancements in the early detection of autism spectrum disorder, Parkinson’s disease and mTBI, through the application of the Clarifi™ epigenetic diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions. Clarifi ASD, an autism diagnostic aid, is the first product to launch commercially from this platform. Clarifi ASD is now available through prescription; details on how to obtain testing are available on Clarifi’s website.